Keywords
PTPN22
Polymorphism
How to Cite
Abstract
Objective: Sarcoidosis is a systemic granulomatous disease with an unknown etiology characterized by noncaseating granuloma formation. It most often affects the lungs. Protein tyrosine phosphatase non-receptor 22 (PTPN22) is a gene that acts as a negative regulator of T-cell activation. Polymorphisms of this gene are associated with multiple human autoimmune diseases. The aim of this study was to assess the relationship between PTPN22 polymorphisms and lung sarcoidosis in a selected population.
Methods: The study included 64 patients with lung sarcoidosis and 30 healthy controls. Patients were genotyped to determine two single nucleotide polymorphisms (SNPs) using the polymerase chain reaction (PCR) method. Hardy–Weinberg equilibrium (HWE), an important tool for detecting genotyping errors, was tested. Direct counting was used to estimate genotype frequencies. Logistic regression analysis was performed to compare allele and genotype frequencies between the patient and control groups.
Results: The results of the study showed no correlation between lung sarcoidosis and the tested two SNPs of the PTPN22 gene (rs2488457, rs1310182) (p>0.05). The categorization analysis according to the clinical features, laboratory, and radiographic characteristics showed no correlation between the tested polymorphism of PTPN22 and these characteristics (p>0.05).
Conclusion: The present study demonstrated that the studied two SNPs of the PTPN22 gene (rs2488457, rs1310182) were not correlated with lung sarcoidosis, suggesting that it might be different from other classic autoimmune disorders. There is a need for more studies to verify these results concerning lung sarcoidosis in other ethnic origins.
References
Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003;361:1111-1118.
Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981;305:429–434.
Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med1983;308:793–800.
Saltini C, Spurzem JR, Lee JJ, Pinkston P, Crystal RG. Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+T cell subset. J Clin Invest1986;77:1962–1970.
Robinson BW, McLemore TL, Crystal RG. Interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985;75:1488–1495.
Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36:337-338.
Siminovitch KA. PTPN22 and autoimmune disease. Nat Genet 2004; 36:1248-1249.
Gregersen PK. Gaining insight into PTPN22 and autoimmunity. Nat Genet 2005; 37:1300-1302.
Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75:330-337.
Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE, Chang M, et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004; 75:504-507.
Michou L, Lasbleiz S, Rat AC, Migliorini P, Balsa A, Westhovens R, et al. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci USA 2007; 104:1649-1654.
Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005; 76:561-571.
Wu H, Cantor RM, Graham DS, Lingren CM, Farwell L, Jager PL, et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 2005; 52:2396-2402.
Purvis HA, Clarke F, Jordan CK, Blanco CS, Cornish GH, Dai X, et al. Protein tyrosine phosphatase PTPN22 regulates IL-1β dependent Th17 responses by modulating dectin-1 signaling in mice. Eur J Immunol. 2018;48:306-315.
Grubic´ Z, Žunec R, Peroš-Golubicic´ T, Tekavec-Trkanjec J, Martinez N, Alilović M, et al. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8. -DRB1*0301, and DQB1*0201 haplotype in clinical variations of disease. Tissue Antigens 2007; 70: 301-306.
Swider C, Schnittger L, Bogunia-Kubik K, Flad H, Lange A, Seitzer U. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonarysarcoidosis. Eur Cytokine Netw 1999;10: 143-146.
Seitzer U, Gerdes J,Müller-Quernheim. Evidence of disease phenotype associated haplotypes (DR.TNF) in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:279-283.
Somoskovi A, Zissel G, Scitzer U, Gerdes J, Schlaak M, Müller- Quernheim J. Polymorphisms at position 308 in the first intron of theTNF-beta genes and spontaneous and lipopolysaccharide-induced TNF-alpha release in sarcoidosis. Cytokine 1999;11:882-887.
Pandey JP, Frederick M, and ACCESS research group. TNF- alpha, IL- beta, and Immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis. Hum Immunology 2002; 63: 485-491.
Udalova IA, Nedosasova SA, Webb GC, Chaplin DD, Teretskaya RL. Higly informative typing the human TNF locus using six adjacent polymorphic markers. Genomics 1993;16:180-186.
Tsukamoto K, Ohta N, Shirai Y, Emi M. A highly polymorphic CA repeat marker at the human tumor necrosis factor alpha (TNFalpha) locus. J Hum Genet 1998; 43: 278-279.
Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, et al; American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):149-173.
Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J. (1961) 2:1165– 72. doi: 10.1136/bmj.2.5261.1165.
Arslan S, Çelik O, Baran A, Güngör S, Akkaya E. Sarkoidoz’daaktivitebelirlemede serum belirteçlerininönemi The importance of serum markers to detect the activity of Sarcoidosis. Ege Journal of Medicine 2010;49(1):41-48.
Burn GL, Svensson L, Sanchez-Blanco C, Saini M, Cope AP. Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS letters 2011;585:3689–3698.
Sahin N, Bicakcigil M, Atagunduz P, DireskeneliH, Saruhan-Direskeneli G. PTPN22 gene polymorphism in Behçet’s disease. Tissue Antigens 2007;70:432–434.
Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham E, Fortune F, et al. The association of the PTPN22 620W polymorphism with Behçet’s disease. Annals of the rheumatic diseases 2007;66: 1531–1533.
Martin TM, Bye L, Modi N, Stanford MR, Vaughan R, Smith JR, et al. Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort. Molecular vision 2009;15:208–212.
Wagenleiter SE, Klein W, Griga T, Schmiegel W, Epplen JT, Jagiello P. A case-control study of tyrosine phosphatase (PTPN22) confirms the lack of association with Crohn's disease. Int J Immunogenet 2005;32(5):323-324.
Matesanz F, Rueda B, Orozco G, Fernandez O, Leyva L, Alcina A, et al. Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis. J Neurol 2005;252(8):994-995.
Kawasaki E, Awata T, Ikegami H, Kobayashi T, Maruyama T, Nakanishi K, et al. Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A. 2006;140(6):586-593.
Ichimura M, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I, et al. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves’ disease in a Japanese population. Thyroid: official journal of the American Thyroid Association 2008;18: 625–630.
Taniyama M, Maruyama T, Tozaki T, Nakano Y, Ban Y. Association of PTPN22 haplotypes with type 1 diabetes in the Japanese population. Human immunology 2010;71:795–798.
Feng X, Li YZ, Zhang Y, Bao SM, Tong DW, Zhang SL, et al. Association of the PTPN22 gene (-1123G > C) polymorphism with rheumatoid arthritis in Chinese patients. Tissue Antigens 2010;76:297-300.
Huang JJ, Qiu YR, Li HX, Sun DH, Yang J, Yang CL. A PTPN22 promoter polymorphism -1123G>C is associated with RA pathogenesis in Chinese. Rheumatol Int 2012;32:767-771.
Orru V, Tsai SJ, Rueda B, Fiorillo E, Stanford SM, Dasgupta J, et al. A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet 2009; 18:569–579.
Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat Genet 2004;36:1312–1318
Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases–a meta-analysis. Rheumatology 2007;46:49–56.
Georas SN, Chapman TJ, Crouser ED. Sarcoidosis and T-helper cells. Th1, Th17, or Th17.1? Am J Respir Crit Care Med 2016;193:1198– 200. doi: 10.1164/rccm.201512-2419ED
Caso F, Galozzi P, Costa L, Sfriso P, Cantarini L, Punzi L. Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn’s disease. RMD Open. (2015) 1:e000097. doi: 10.1136/rmdopen-2015-000097.
Spalinger MR, McCole DF, Rogler G, Scharl M. Role of protein tyrosine phosphatases in regulating the immune system: implications for chronic intestinal inflammation. Inflamm Bowel Dis2015;2:645-655.
Ghorban K, Ezzeddini R, Eslami M, Yousefi B, Sadighi Moghaddam B, Tahoori MT, et al. PTPN22 1858 C/T polymorphism is associated with alteration of cytokine profiles as a potential pathogenic mechanism in rheumatoid arthritis. Immunol Lett2019;216:106-113.
Ramos-Casals M, Retamozo S, Sisó-Almirall A, Pérez-Alvarez R, Pallarés L, Brito-Zerón P. Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis. Expert Rev Clin Immunol 2019;15(4):391-405.
Mortaz E, Sereshki HA, Abedini A, Kiani A, Mirsaeidi M, Soroush D,et al. Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis. J Inflamm (Lond) 2015;12:21.
Chen ES, Moller DR. Etiologies of Sarcoidosis. Clin Rev Allergy Immunol 2015;49(1):6-18.
Rothkrantz-Kos S, Dieijen-Vesser MP, Mulder PGH, Drent M. Potential usefulness of 380 inflammatory markers to monitor respiratory functional impairment in sarcoidosis. 381 Clinical Chemistry 2003;49:1510–1517.
Tanoue LT, Elias JA. Systemic sarcoidosis. In: BaumGL, Crapo JD, Celi BR, Karlinsky JB, 410 editors. Textbook of pulmonary disease. 6th ed. Philadelphia: Lippincott-Raven Pub- 411 lishers; 1998. p. 407–30.
Baughman RP, Shipley R, Desai S, Drent M, Judson MA, Costabel U, et al. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. Chest. 2009; 136:526–35.
Judson MA, Gilbert GE, Rodgers JK, Greer CF, Schabel SI. The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis. Respirology 2008;13:97–102.
This work is licensed under a Creative Commons Attribution 4.0 International License.